Phase II study with gemcitabine and paclitaxel administered once every two weeks in chemonaive advanced stage non-small cell lung cancer (NSCLC) patients
Fontaine, C, Joos, G, De Grève, J, De Mey, J, Van Klaveren, R, Neyns, B, Van de Velde, V, Stappaerts, I, Pinson, P, Grauwels, D, Van Hulle, J, Schallier, DVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80044-6
Date:
September, 2000
File:
PDF, 106 KB
english, 2000